Sun Pharma, Teva to settle patent suit tied to acid-reflux med for $2.15B

06/13/2013 | Reuters

Teva Pharmaceutical Industries and Sun Pharmaceutical Industries agreed to settle a patent-infringement lawsuit connected to Pfizer and Takeda Pharmaceutical's acid-reflux treatment Protonix for $2.15 billion. The two makers of generic drugs are accused of marketing a copy of an existing treatment with unexpired patents. "It is an important milestone, setting a 'book-end' case for the industry," said Bernstein Research analyst Aaron Gal. "It will serve to encourage patent settlements."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX